化合物Zabedosertib T37076
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
10 mg | 1931994-81-8 | ¥894.00 | 询底价 |
25 mg | 1931994-81-8 | ¥1,590.00 | 询底价 |
500 mg | 1931994-81-8 | 面议 | 询底价 |
5 mg | 1931994-81-8 | ¥571.00 | 询底价 |
1 mL | 1931994-81-8 | ¥738.00 | 询底价 |
100 mg | 1931994-81-8 | ¥3,390.00 | 询底价 |
2 mg | 1931994-81-8 | ¥353.00 | 询底价 |
1 mg | 1931994-81-8 | ¥256.00 | 询底价 |
50 mg | 1931994-81-8 | ¥2,370.00 | 询底价 |
Product Introduction
Bioactivity
英文名: Zabedosertib
描述: Zabedosertib (BAY 1834845) 是一种 IRAK4 抑制剂,具有免疫调节潜能。最新研究表明,Zabedosertib 可预防急性呼吸窘迫综合征
体内活性: In an inhaled lipopolysaccharide (LPS)-induced ARDS mouse model, BAY-1834845 downregulated genes more efficiently than dexamethasone, especially TNF, IL-17, interferon, and Toll-like receptor signaling[1].
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 112.5 mg/mL (239.1 mM)
关键字: BAY1834845 | Zabedosertib | BAY-1834845
相关产品: IRAK4-IN-7 | Zimlovisertib | IRAK inhibitor 1 | HS271 | IRAK4-IN-26 | CA-4948 | Larotinib | ANTHRAQUINONE-2-CARBOXYLIC ACID | IRAK-1-4 Inhibitor I | AZ1495
相关库: Drug Repurposing Compound Library | Anti-Cancer Compound Library | Anti-Cancer Drug Library | NF-κB Signaling Compound Library | Clinical Compound Library | Bioactive Compounds Library Max | Kinase Inhibitor Library | Inhibitor Library | Anti-Cancer Clinical Compound Library | Bioactive Compound Library
化合物Zabedosertib T37076信息由TargetMol中国为您提供,如您想了解更多关于化合物Zabedosertib T37076报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途